Clinical Trials Browser

Phase 1/2 × Hyperinsulinism × 1 year × Clear all

NCT05455619 2025-05-29

Amelia-1

Phase 1/2 Recruiting

Breast Neoplasms, Hyperglycemia, Hyperinsulinism, Insulin Resistance